We don’t know everything, but we are not completely in the dark
Board Member Peter Kellner writes about the role of the Medicines Discovery Catapult and the importance of collaboration post-Brexit Britain’s long-term prospects, post-Brexit, will plainly be affected by our trading arrangements with the rest of Europe and the wider world. The full impact may not be clear for some years. But, as this week’s industrial […]
A new approach for 2017
As 2017 begins, we are looking forward to new beginnings, new ways of thinking and new approaches to medicines discovery. 2016 was an eventful year across the globe, and changes in the political landscape will undoubtedly affect the biopharma industry, creating an atmosphere of inevitable uncertainty. On the bright side, though, investment in Life Sciences […]
A problem shared…
CEO Chris Molloy explains why collaboration is essential to the discovery of new and effective medicines. As 2016 ends, we are looking forward to an exciting New Year at the Medicines Discovery Catapult (MDC). We are building new facilities, investing in cutting edge equipment, attracting talented people and planning impactful projects as we begin our […]
Putting Patients First
CEO Chris Molloy explains why patients and medical research charities are so vital to the work of Medicines Discovery Catapult. Next week the Medicines Discovery Catapult will be joining representatives of industry and medical research charities at the Patients First conference, organised by AMRC and ABPI . We will be exhibiting and sponsoring a panel […]
Medicines technology: bringing innovation, health and wealth to the UK
Incoming Chief Executive for the Medicines Discovery Catapult, Chris Molloy, gives his thoughts on the value of medicines discovery technology as a national asset. In November I’ll be in post as Chief Executive at the Medicines Discovery Catapult. So, I was interested to hear the recent news that George Osborne will be chairing the Northern Powerhouse Partnership, a […]
Kate Bellingham: Championing girls’ opportunities in STEM
Kate Bellingham, Medicines Discovery Catapult Board Member, is a passionate champion for girls’ opportunities in engineering. With a degree in Physics, an MSc in Electronics and GTP teaching qualifications, she has worked as a computer programmer, broadcast engineer, TV and radio presenter (including 4 years on BBC TV’s ‘Tomorrow’s World’), secondary school maths and physics […]
The Medicines Discovery Catapult: a ripple of excitement as we start our journey
The Medicines Discovery Catapult is embarking on an exciting journey as the first of its kind in the UK. When it takes up residency at Alderley Park over the next few months, the centre of national expertise will start supporting industry to develop new approaches for the discovery and development of new medicines. What’s vital […]